Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/04/1997 | CA2257110A1 Screen for ultraspiracle inhibitors |
12/04/1997 | CA2256900A1 Cationic polymer/lipid nucleic acid delivery vehicles |
12/04/1997 | CA2256756A1 Recombinant plant genome, comprising specific chicory genes and a nucleotide sequence conferring male sterility, and its use. |
12/04/1997 | CA2256577A1 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease |
12/04/1997 | CA2256498A1 Cell growth regulatory genes |
12/04/1997 | CA2256481A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |
12/04/1997 | CA2256455A1 Identification of genes altered in multiple myeloma |
12/04/1997 | CA2256453A1 Lactoferrin variants and uses thereof |
12/04/1997 | CA2256372A1 Apoptosis associated protein bbk |
12/04/1997 | CA2256368A1 An interleukin-5 antagonist |
12/04/1997 | CA2256358A1 Compositions and methods for antisense inhibition of protein translation |
12/04/1997 | CA2256312A1 Prion protein binding proteins and uses thereof |
12/04/1997 | CA2255941A1 Prevention of graft-versus-host disease with t-cells including polynucleotides encoding negative selective markers |
12/04/1997 | CA2255830A1 Use of a novel glucosyl transferase |
12/04/1997 | CA2254828A1 Identification of pyrazinamide-resistant mycobacteria and methods for treating mycobacterial infections |
12/04/1997 | CA2253818A1 Mammalian tolloid-like gene and protein |
12/04/1997 | CA2247995A1 Methods and compositions for determining the tumor suppressor status of cells |
12/03/1997 | EP0810289A1 Starter strains expressing a protease of Lactobacillus bulgaricus |
12/03/1997 | EP0810288A2 A new DNA polymerase with proof-reading 3'-5' exonuclease activity |
12/03/1997 | EP0810287A1 Genes coding for proteins having acyl transfer activity |
12/03/1997 | EP0810285A2 Mutants of human Interleukin-3 |
12/03/1997 | EP0810284A1 Cytoplasmic male sterile Brassica oleracea plant and method for obtaining such plant |
12/03/1997 | EP0810282A2 Process for obtaining improved strains of trichoderma spp. |
12/03/1997 | EP0810230A2 Anti-HIV antibodies used as control probes |
12/03/1997 | EP0810030A1 Apparatus and containers for performing polymerase chain reaction |
12/03/1997 | EP0809806A1 Monoclonal antibodies for human osteogenic cell surface antigens |
12/03/1997 | EP0809796A1 Optical cuvette |
12/03/1997 | EP0809711A1 Amplification of nucleic acids and detection of a new non-a, non-b, non-c, non-d, non-e hepatitis virus |
12/03/1997 | EP0809710A2 Detection of bacteria of genus listeria using nucleic probe hybridisation techniques |
12/03/1997 | EP0809707A1 Microorganism of genus chrysosporium for use in preparing farnesyl transferase inhibitors |
12/03/1997 | EP0809705A1 Nucleic acid-containing composition, preparation and use thereof |
12/03/1997 | EP0809704A1 Method for preparing a recombinant adenovirus genome |
12/03/1997 | EP0809703A1 Methods for maintaining sterility in plants |
12/03/1997 | EP0809702A1 Plasmid-derived type ii restriction-modification systems from lactococcus lactis |
12/03/1997 | EP0809701A1 Calcineurin regulatable adenylate cyclase |
12/03/1997 | EP0809700A1 Papilloma virus-like particles, fusion proteins and process for producing the same |
12/03/1997 | EP0809699A1 New chemokines expressed in pancreas |
12/03/1997 | EP0809698A1 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE Int6 |
12/03/1997 | EP0809697A2 Human peroxisome proliferator activated receptors gamma |
12/03/1997 | EP0809696A1 Novel allele of human histamine h2 receptor and methods of detection of h2 receptor variants |
12/03/1997 | EP0809695A1 Transcription factor - e2f-5 |
12/03/1997 | EP0809692A1 Materials and methods relating to the regulation of polypeptide production in cells |
12/03/1997 | EP0809656A1 MONOCLONAL ANTIBODY SPECIFIC FOR $g(b)A4 PEPTIDE |
12/03/1997 | EP0809655A1 PEPTIDES AND PEPTIDOMIMETICS WITH STRUCTURAL SIMILARITY TO HUMAN p53 THAT ACTIVATE p53 FUNCTION |
12/03/1997 | EP0809649A1 HETEROLOGOUS POLYPEPTIDE PRODUCTION IN THE ABSENCE OF NONSENSE-MEDIATED mRNA DECAY FUNCTION |
12/03/1997 | EP0809648A1 Neuropeptide y receptor |
12/03/1997 | EP0809517A1 Anti-transforming growth factor-beta gene therapy |
12/03/1997 | EP0809516A1 Medicinal combination useful for in vivo exogenic transfection and expression |
12/03/1997 | EP0809500A1 Novel glucocorticoid response elements |
12/03/1997 | EP0809432A1 Transgenic grasses |
12/03/1997 | EP0746343A4 METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE -i(IN VIVO) OR -i(EX VIVO) |
12/03/1997 | EP0730651A4 Surface loop structural analogues of fibroblast growth factors |
12/03/1997 | EP0707659B1 Salmonella identification by the polymerase chain reaction |
12/03/1997 | EP0600866B1 Compositions and methods for identifying biologically active molecules |
12/03/1997 | EP0533838B1 Nucleic acid ligands |
12/03/1997 | EP0528828B2 Alkaline bacillus lipases, coding dna sequences therefor and bacilli which produce these lipases |
12/03/1997 | CN1166859A DNA encoding the-i(bacillus licheniformis) PWD-1 keratinase |
12/03/1997 | CN1166858A The tagA gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma |
12/03/1997 | CN1166857A New E. coli mutant with suppressed organic acid production |
12/03/1997 | CN1166838A Antibodies against allogenic and Xenogenic proteins, their use in diagnosis and therapy and methods for determination thereof |
12/03/1997 | CN1166837A Chromosome 21 gene marker, compositions and methods using same |
12/03/1997 | CN1166527A High-efficiency conversion system of kluyveromyces fragilis yeast |
12/03/1997 | CN1166526A Aminopeptidase GX, and method of hydrolyzing protein with the same |
12/03/1997 | CA2196834A1 Promoter for expressing foreign genes in monocotyledonous plants |
12/02/1997 | US5693785 Binding dna to alkali-treated acidified silica without binding reagents or chaotropes |
12/02/1997 | US5693783 Nucleic acid probes specifically hybridizing to contiguous nucleotide sequences; kits |
12/02/1997 | US5693781 Promoter DNA fragment from coryneform bacteria |
12/02/1997 | US5693779 Isolated polynucleotide encoding protein useful for treating or preventing syndromes involving inappropriate tissue proliferation |
12/02/1997 | US5693778 Purified dna molecule having specified nucleotide sequence |
12/02/1997 | US5693777 DNA encoding pasteurella haemolytica PhaI restriction endonuclease and methyltransterase |
12/02/1997 | US5693776 Nucleic acids specific for Rochalimaea quintana |
12/02/1997 | US5693775 Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use |
12/02/1997 | US5693774 DNA sequences involved in soraphen biosynthesis by myxobacteria |
12/02/1997 | US5693773 Capable of hybridizing to and inhibiting expression of nucleic acids having mixed purine/pyrimidine sequences by triplex formation; comprises three regions-duplex forming region, triplex forming region and linker region |
12/02/1997 | US5693769 Glycosylated steroid derivatives for transport across biological membranes and process for making and using same |
12/02/1997 | US5693762 Humanized immunoglobulins |
12/02/1997 | US5693761 Genetic engineering; complementarity zones |
12/02/1997 | US5693757 Huntingtin DNA, protein and uses thereof |
12/02/1997 | US5693755 Construction and expression of synthetic genes encoding envelopes of human T cell leukemia virus type I |
12/02/1997 | US5693753 Method of isolating βA4 peptide species ending at carboxy-terminals residue 42 using monoclonal antibody 369.2B |
12/02/1997 | US5693752 Hexapeptides of specified amino acid sequences |
12/02/1997 | US5693622 By injecting a non-integrating dna sequence operably linked to a promoter in the absence of transfection-facilitating proteins, viral particles, liposomal formulations, charged lipids, and calcium phosphate precipitating agents |
12/02/1997 | US5693616 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
12/02/1997 | US5693609 Antidiabetic agents; extended duration of action |
12/02/1997 | US5693536 Introducing wild-type mutated colorectal cancer gene into cell which has lost this function, then gene expression for antitumor activity |
12/02/1997 | US5693535 Enzymatic nucleic acid molecule which specifically cleaves rna sequence |
12/02/1997 | US5693532 Respiratory syncytial virus ribozymes |
12/02/1997 | US5693531 Vector systems for the generation of adeno-associated virus particles |
12/02/1997 | US5693530 Recombinant vectors; vaccines |
12/02/1997 | US5693522 Anti-cancer immunotherapeutics |
12/02/1997 | US5693520 Recombinant trypsin-like protease |
12/02/1997 | US5693519 Thermostable, salt tolerant, wide pH range novel chitobiase |
12/02/1997 | US5693518 Enzymes with xylanase activity from Aspergillus aculeatus |
12/02/1997 | US5693517 Reagents and methods for coupled high temperature reverse transcription and polymerase chain reactions |
12/02/1997 | US5693512 Method for transforming plant tissue by sonication |
12/02/1997 | US5693511 Immortalized human fetal osteoblastic cells |
12/02/1997 | US5693510 Genetically engineered fungus cells(ascomycetes) which produce reduced amounts of carboxypeptidase |
12/02/1997 | US5693509 Adenovirus for delivering foreign DNA into higher eukaryotic cells |
12/02/1997 | US5693508 Retroviral expression vectors containing MoMLV/CMV-IE/HIV-TAR chimeric long terminal repeats |
12/02/1997 | US5693507 Genetic engineering of plant chloroplasts |